Diagnostic tissue or organ via ligand-specific uptake (gamma-emitting radiopharmaceutical)

The target refers to any tissue or organ that selectively accumulates a radiopharmaceutical based on ligand-specific uptake and retention, allowing gamma-ray emission to be detected by external imaging tools such as gamma cameras or SPECT scanners. Common diagnostic radiopharmaceuticals exploit biological processes (e.g., glucose metabolism) or organ-specific transport to concentrate in areas of interest (such as tumors, inflamed regions, or functioning myocardium), leading to emission of gamma photons. These photons penetrate body tissues and are captured by imaging devices that reconstruct the anatomical and functional distribution of the tracer, thus facilitating diagnosis, staging, and treatment planning in conditions like cancer, heart disease, and neurologic disorders.

Other names

Imaging target (tissue/organ)SPECT/PET imaging siteRadiotracer-accumulating tissue

Ligand-specific targeting: Radiopharmaceutical binds a physiological process or molecular structure in tissue or organ, emits gamma rays detected externally